M-0324

N/A

Report date: 2025/09/11 20:00:08

Base Information

Drug NameM-0324
Drug Alias NameM-0324M0324
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionTumor necrosis factor receptor superfamily member 5 agonistsAnti-MUC1
TargetsTumor necrosis factor receptor superfamily member 5Mucin-1
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesGermany +[4] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMerck KGaA, Darmstadt, Germany
China Registration ClassN/A

Develop Information

Active CompaniesEmd Serono Research & Development Institute IncMerck KGaA, Darmstadt, Germany
Inactive CompaniesEmd Serono Inc
Active IndicationsSolid tumours
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A